GOLD IRWIN

Co-Chairman Gold Irwin sold 6,811 shares of HLI at $202.75 on 2025-09-16, total value $1,380,930.25.

Gold Irwin, Co-Chairman of Houlihan Lokey, sold 6,811 shares at $202.75 per share on 2025-09-16, representing the entire disclosed equity position in the filed table. This sale occurred near the 52-week high of $208.44, with the stock up 8.5% over the past 30 days and 20.5% over 90 days. Notably, Irwin's two prior sales at HLI showed mixed timing outcomes: the June 2024 sale was followed by a +10.9% 30-day return and +17.0% 90-day return, while the December 2023 sale saw -1.0% 30-day and +2.0% 90-day returns. The company reported revenue of $605,349,000 for the latest quarter with net income of $97,533,000, and annual revenue growth of +24.8%. A FLAG indicates this filing contains a derivative-conversion transaction, meaning the insider's full position may extend to Table II derivative securities not yet populated in our database—this sale should be viewed as a specific batch transaction rather than a complete position exit.

Co-Chairman Gold Irwin sold 9,902 shares of HLI at $135.25 on 2024-06-28; derivative conversion context, not full exit.

Gold Irwin, HLI Co-Chairman, sold 9,902 shares at $135.25 on 2024-06-28 in a derivative-conversion transaction. This filing involves a conversion of derivative securities, meaning the insider's full position resides in Table II of the Form 4 (not yet populated in our database), and the Table I shares represent only a specific batch being converted and sold—not a complete position liquidation. At the prior HLI sale on 2023-12-27, the stock posted a +2.0% return over 90 days, meaning the insider sold into subsequent gains; this pattern suggests the sale was not well-timed at the longer horizon. The current stock price of $136.24 is -0.4% from the 52-week high of $136.80, placing this transaction near recent peak valuations.